Background: Research indicates that lesbian, gay, bisexual, transgender, and queer plus (LGBTQ+) individuals are approximately 25% less likely to pursue preventative cancer screenings compared to their cisgender or heterosexual counterparts. Human immunodeficiency virus (HIV) disproportionately impacts LGBTQ+ individuals, particularly those who are transgender or men who have sex with men (MSM). Immunodeficient patients, like HIV+ persons, face elevated risks of HPV-related cancers. These reasons emphasize the importance of offering HPV cancer screenings to eligible HIV+ and/or at-risk LGBTQ+ persons. Methods: The Plan-Do-Study-Act model was utilized for this quality improvement (QI) project. Baseline data included the number of current established patients and their general demographics (gender, HIV status, age) and the number of completed HPV anal pap tests within the year prior to the intervention. These numbers were also reviewed following the intervention. A literature review was conducted to identify specific population concerns and educational methods for implementation. Intervention: Three patient education pieces were created: a simplified flyer or promo for social media, an informational one-pager for physical posters, and a detailed slide-based presentation with voiceover. An anonymous patient survey was provided for completion by individuals undergoing pap testing to evaluate the effectiveness of the intervention materials. Results: In 2023, the clinic reported zero anal pap tests. After the implementation of the intervention, two anal pap tests were completed, with a third occurring after the implementation period. Patients reported doing so because of the education modalities. Conclusion: Multimodal patient education has the potential to increase HPV anal cancer screening rates.
Read
